These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3260286)

  • 1. Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor.
    Robertson DW; Krushinski JH; Fuller RW; Leander JD
    J Med Chem; 1988 Jul; 31(7):1412-7. PubMed ID: 3260286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1986 Feb; 24(2):281-4. PubMed ID: 3485293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo.
    Fuller RW; Snoddy HD; Krushinski JH; Robertson DW
    Neuropharmacology; 1992 Oct; 31(10):997-1000. PubMed ID: 1279447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers.
    Fuller RW; Snoddy HD
    Biochem Pharmacol; 1993 Jun; 45(11):2355-8. PubMed ID: 8517878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors.
    Hynes MD; Lochner MA; Bemis KG; Hymson DL
    Life Sci; 1985 Jun; 36(24):2317-23. PubMed ID: 2989631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors.
    Wong DT; Fuller RW; Robertson DW
    Acta Pharm Nord; 1990; 2(3):171-80. PubMed ID: 2200429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain.
    Wong DT; Bymaster FP; Reid LR; Mayle DA; Krushinski JH; Robertson DW
    Neuropsychopharmacology; 1993 Jun; 8(4):337-44. PubMed ID: 8512621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance.
    Larson AA; Takemori AE
    Life Sci; 1977 Dec; 21(12):1807-11. PubMed ID: 604708
    [No Abstract]   [Full Text] [Related]  

  • 11. Analgesic effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake.
    Messing RB; Phebus L; Fisher LA; Lytle LD
    Psychopharmacol Commun; 1975; 1(5):511-21. PubMed ID: 132683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic action of p-chloroamphetamine and fluoxetine on food and water consumption patterns in the rat.
    Stein JM; Wayner MJ; Kantak KM; Adler-Stein RL
    Pharmacol Biochem Behav; 1978 Nov; 9(5):677-85. PubMed ID: 310559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
    Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
    Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors.
    Fuller RW; Snoddy HD; Molloy BB
    Psychopharmacol Commun; 1975; 1(5):455-64. PubMed ID: 1228825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine suppresses palatability-induced ingestion.
    Leander JD
    Psychopharmacology (Berl); 1987; 91(3):285-7. PubMed ID: 3104951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine.
    Fuller RW; Perry KW; Molloy BB
    Eur J Pharmacol; 1975 Aug; 33(1):119-24. PubMed ID: 126166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats.
    Fuller RW; Owen JE
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):137-40. PubMed ID: 6975958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.
    Fuller RW; Perry KW; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):793-803. PubMed ID: 1151729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
    Schmidt CJ; Levin JA; Lovenberg W
    Biochem Pharmacol; 1987 Mar; 36(5):747-55. PubMed ID: 2881549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.